Febrile
Neutropenia - Pipeline Review, H2 2014
Summary
Global Markets
Direct's, 'Febrile Neutropenia - Pipeline Review, H2 2014', provides an
overview of the Febrile Neutropenia's therapeutic pipeline.
This report provides
comprehensive information on the therapeutic development for Febrile
Neutropenia, complete with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic development
for Febrile Neutropenia and special features on late-stage and discontinued
projects.
Access
Full Report With TOC @ http://www.radiantinsights.com/research/febrile-neutropenia-pipeline-review-h2-2014
Global Markets Direct's
report features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using data and
information sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team. Drug profiles/records
featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of
information. Additionally, processes including live news & deals tracking,
browser based alert-box and clinical trials registries tracking ensure that the
most recent developments are captured on a real time basis.
The report enhances
decision making capabilities and help to create effective counter strategies to
gain competitive advantage. It strengthens R&D pipelines by identifying new
targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections
in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
Scope
- The report provides a
snapshot of the global therapeutic landscape of Febrile Neutropenia
- The report reviews
key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details &
other developmental activities
- The report reviews
key players involved in the therapeutics development for Febrile Neutropenia
and enlists all their major and minor projects
- Latest news and deals
relating related to pipeline products
Reasons
to buy
- Provides
strategically significant competitor information, analysis, and insights to
formulate effective R&D development strategies
- Identify emerging
players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop strategic
initiatives by understanding the focus areas of leading companies
About
Radiant Insights
Radiant Insights is a
platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For
more information visit, Radiant Insights
Contact
Details:
Michelle Thoras
Corporate Sales
Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free:
1-888-202-9519
No comments:
Post a Comment